Boc-Leu-Gly-OH
Need Assistance?
  • US & Canada:
    +
  • UK: +

Boc-Leu-Gly-OH

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Others
Catalog number
BAT-004947
CAS number
32991-17-6
Molecular Formula
C13H24N2O5
Molecular Weight
288.34
Boc-Leu-Gly-OH
IUPAC Name
2-[[(2S)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]amino]acetic acid
Synonyms
(S)-2-(2-((Tert-Butoxycarbonyl)Amino)-4-Methylpentanamido)Acetic Acid; Glycine, N-[(1,1-Dimethylethoxy)Carbonyl]-L-Leucyl-; N-(Tert-Butoxycarbonyl)-L-Leucylglycine
Appearance
White powder
Purity
≥ 99% (TLC)
Density
1.122±0.06 g/cm3(Predicted)
Melting Point
120-124º C
Boiling Point
499.6±30.0 °C(Predicted)
Storage
Store at 2-8 °C
InChI
InChI=1S/C13H24N2O5/c1-8(2)6-9(11(18)14-7-10(16)17)15-12(19)20-13(3,4)5/h8-9H,6-7H2,1-5H3,(H,14,18)(H,15,19)(H,16,17)/t9-/m0/s1
InChI Key
NRXDUMDULDHIEA-VIFPVBQESA-N
Canonical SMILES
CC(C)CC(C(=O)NCC(=O)O)NC(=O)OC(C)(C)C
1. Synthetic and biological studies on a cyclopolypeptide of plant origin
Rajiv Dahiya, Akhilesh Kumar J Zhejiang Univ Sci B. 2008 May;9(5):391-400. doi: 10.1631/jzus.B0720001.
Objective: A natural cyclic peptide previously isolated from Citrus medica was synthesized by coupling of tetrapeptide units Boc-Leu-Pro-Trp-Leu-OMe and Boc-Ile-Ala-Ala-Gly-OMe after proper deprotection at carboxyl and amino terminals followed by cyclization of linear octapeptide segment. Methods: Solution phase technique was adopted for the synthesis of cyclooctapeptide-sarcodactylamide. Required tetrapeptide units were prepared by coupling of Boc-protected dipeptides viz. Boc-Leu-Pro-OH and Boc-Ile-Ala-OH with respective dipeptide methyl esters Trp-Leu-OMe and Ala-Gly-OMe. Cyclization of linear octapeptide unit was done by p-nitrophenyl ester method. The structure of synthesized cyclopolypeptide was elucidated by FTIR, 1H NMR, 13C NMR, FABMS spectral data and elemental analysis. The newly synthesized peptide was evaluated for different pharmacological activities including antimicrobial, anthelmintic and cytotoxic activities. Results: Synthesis of sarcodactylamide was accomplished with >78% yield utilizing dicyclohexylcarbodiimide (DCC) as coupling agent. Newly synthesized peptide possessed potent cytotoxic activity against Dalton's lymphoma ascites (DLA) and Ehrlich's ascites carcinoma (EAC) cell lines, in addition to moderate anthelmintic activity against earthworms Megascoplex konkanensis, Pontoscotex corethruses and Eudrilus sp. Moreover, cyclopolypeptide displayed good antimicrobial activity against pathogenic fungi Candida albicans and Gram-negative bacteria Pseudomonas aeruginosa, in comparison to standard drugs griseofulvin and ciprofloxacin. Conclusion: Solution phase technique employing DCC and triethylamine (TEA) as base proved to be effective for the synthesis of natural cyclooctapeptide. N-methyl morpholine (NMM) was found to be a better base for the cyclization of linear octapeptide unit in comparison to TEA and pyridine.
2. Synthesis, structure, and properties of MeSer1-tentoxin, a new cyclic tetrapeptide which interacts specifically with chloroplast F1 H(+)-ATPase differentiation of inhibitory and stimulating effects
E Pinet, F Cavelier, J Verducci, G Girault, L Dubart, F Haraux, C Sigalat, F André Biochemistry. 1996 Oct 1;35(39):12804-11. doi: 10.1021/bi960955n.
A new tentoxin analogue, in which the L-methyl alanine residue is substituted by L-methylserine, has been prepared following the synthetic pathway recently described for the synthesis of tentoxin [Cavelier, F., & Verducci, J. (1995) Tetrahedron Lett. 36, 4425-4428]. Using two-dimensional homonuclear proton nuclear magnetic resonance and structural analysis, we observed that MeSer1-tentoxin, like tentoxin, adopts several conformations in aqueous solution and presents self-aggregative properties. This analogue was found to be conformationally similar to the natural toxin. It showed the same efficiency as tentoxin in inhibition of ATPase activity of the isolated chloroplast F1 proton ATPase (CF1) as well as in inhibition of the ATP synthase activity of the membrane-bound enzyme (CF0CF1) in thylakoids and proteoliposomes. At concentrations above 10 microM, MeSer1-tentoxin did not reactivate CF1 to a high extent, contrary to tentoxin. It appeared, however, to bind in the same way, since the reactivating effect of tentoxin was inhibited by MeSer1-tentoxin. These results show that it is possible, using tentoxin analogues, to separate inhibitory and activating effects on the chloroplast ATPase, despite the limited chemical difference between the two toxins.
3. Tentoxin as a scaffold for drug discovery. Total solid-phase synthesis of tentoxin and a library of analogues
Jose C Jiménez, Bibiana Chavarría, Angel López-Macià, Miriam Royo, Ernest Giralt, Fernando Albericio Org Lett. 2003 Jun 12;5(12):2115-8. doi: 10.1021/ol0345273.
[reaction: see text] A solid-phase method for the synthesis of tentoxin has been developed. Two key steps-dehydration and N-alkylation-are carried out while the peptide is anchored to the resin. The method, which has been validated by the preparation of a library of tentoxin analogues, should be applicable to the generation of further libraries that have the tentoxin scaffold structure, as well as other structures containing N-alkylated didehydroamino acids.
Online Inquiry
Verification code
Inquiry Basket